Target Information
General Information of This Target (ID: PATR0EDEOX)
| Target Name | Bcl-2-like protein 1 (BCL2L1) |
|||||
|---|---|---|---|---|---|---|
| Gene Name | BCL2L2; BCLW; KIAA0271 |
|||||
| Gene ID | ||||||
| Synonym | BCLW; KIAA0271 |
|||||
| Sequence |
MATPASAPDTRALVADFVGYKLRQKGYVCGAGPGEGPAADPLHQAMRAAGDEFETRFRRT
FSDLAAQLHVTPGSAQQRFTQVSDELFQGGPNWGRLVAFFVFGAALCAESVNKEMEPLVG QVQEWMVAYLETQLADWIHSSGGWAEFTALYGDGALEEARRLREGNWASVRTVLTGAVAL GALVTVGAFFASK Click to Show/Hide
|
|||||
| Family | Bcl-2 family |
|||||
| Function |
FUNCTION: Involved in the regulation of apoptosis versus cell survival, and in the maintenance of viability but not of proliferation. Mediates its effects by interactions with a number of other regulators of apoptosis. Isoform 1 inhibits apoptosis. Isoform 2 promotes apoptosis. {ECO:0000269|PubMed:10766760, ECO:0000269|PubMed:16543145}.
Click to Show/Hide
|
|||||
| Uniprot Entry | ||||||
| HGNC ID | ||||||
| KEGG ID | ||||||
Full List of The ADC Related to This Target
Phase 1
| ADC Name | Antibody | Antigen | Payload | Linker | ADC Info |
|---|---|---|---|---|---|
|
Mirzotamab clezutoclax
|
Mirzotamab |
CD276 antigen (CD276) |
clezutoclax |
Val-Ala dipeptide linker |
|
|
ABBV-637
|
Anti-EGFR antibody |
Epidermal growth factor receptor (EGFR) |
BCL-xL inhibitor |
Undisclosed |
